Abstract
Background We reviewed the risk of second tumor (ST), both malignant and benign, in germinoma survivors followed at the Johns Hopkins Hospital (JHH). Methods Between 1977 and 2002, 27 patients with intracranial germinoma were treated with radiation therapy (RT). In the presence of competing events, a cumulative incidence function of ST was estimated using the minimal time interval from the date of diagnosis to the date of ST, date of death, or date of last follow-up. Results Five patients (18%) developed a ST of which 4 (15%) were malignant. One developed a benign falcine meningioma. The cumulative incidence of ST was 9% at 11 years (95% CI, 0–22%). Conclusions The relative contributions of RT and patient susceptibility to a ST cannot be determined but suggests the need for long-term surveillance, including testicular self-exams in male germinoma survivors. Current trials of chemotherapy and reduced RT dose and volume offer the prospect of a lower risk of treatment-induced ST.
Similar content being viewed by others
References
Maity A, Shu H-KG, Janss A, Belasco JB, Rorke L, Phillips PC, Sutton LN, Goldwein JW (2004) Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years’ experience in a single center. Int J Radiat Oncol Biol Phys 58:1165–1170
Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U (1999) Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592
Hardenbergh PH, Golden J, Billet A, Scott RM, Shrieve DC, Silver B, Loeffler JS, Tarbell NJ (1997) Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys 39:419–426
Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S, Finlay JL (1996) Chemotherapy without irradiation—a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 14:2908–2915
Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL (2004) Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol. J Clin Oncol 22:846–853
Baranzelli MC, Patte C, Bouffet E, Couanet D, Habrand JL, Portas M, Lejars O, Lutz P, Le Gall E, Kalifa C (1997) Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer 80:1792–1797
Sawamura Y, Shirato H, Ikeda J, Tada M, Ishii N, Kato T, Abe H, Fujieda K (1998) Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 88:66–72
Merchant TE, Sherwood SH, Mulhern RK, Rose SR, Thompson SJ, Sanford RA, Kun LE (2000) CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 46:1171–1176
Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93:618–629
MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML (2007) Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 48:453–459
Kalbfeish JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. JASA 94:496–506
Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H (1998) Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer 34:104–110
Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J (2006) An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors [see comment]. Pediatr Blood Cancer 47:83–88
Daniel C, Fizazi K, Culine S, Zelek L, Wibault P, Theodore C (2001) Metachronous gonadal and extragonadal primaries, or late relapse of germ cell tumor? Urol Oncol 6:49–52
Goldstein AM, Yuen J, Tucker MA (1997) Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 8:865–871
Duffner PK, Krischer JP, Horowitz ME, Cohen ME, Burger PC, Friedman HS, Kun LE (1998) Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study [see comment]. Ann Neurol 44:313–316
Morris EB, Gajjar A, Okuma JO, Yasui Y, Wallace D, Kun LE, Merchant TE, Fouladi M, Broniscer A, Robison LL, Hudson MM (2007) Survival and late mortality in long-term survivors of pediatric CNS tumors. J Clin Oncol 25:1532–1538
Witherby SM, Butnor KJ, Grunberg SM, Witherby SM, Butnor KJ, Grunberg SM (2007) Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer 57:410–413
Brown LM, Howard RA, Travis LB, Brown LM, Howard RA, Travis LB (2006) The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma [comment]. Cancer 107:2741–2742 author reply 2742
Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES, Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES (2005) Second cancers among 40, 576 testicular cancer patients focus on long-term survivors. J Natl Cancer Inst 97:1354–1365
Das P, Ng AK, Stevenson MA, Mauch PM (2005) Clinical course of thoracic cancers in Hodgkin’s disease survivors. Ann Oncol 16:793–797
Sato F, Yamazaki H, Ataka K, Mashima I, Suzuki K, Takahashi T, Umezu H, Gejyo F (2000) Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis. Intern Med 39:920–924
Strojan P, Popovi M, Jereb B (2000) Secondary intracranial meningiomas after high-dose cranial irradiation report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 48:65–73
Ron E, Modan B, Boice JD Jr, Alfandry E, Stovall M, Chetrit A (1988) Katz L Tumors of the brain and nervous system after radiotherapy in childhood. N Eng J Med 319:1033–1039
Goshen Y, Stark B, Kornreich L, Michowiz S, Feinmesser M, Yaniv I (2007) High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49:294–297
Bosl GJ, Dmitrovsky E, Reuter VE, Samaniego F, Rodriguez E, Geller NL, Chaganti RS (1989) Isochromosome of the short arm of chromosome 12 clinically useful markers for male germ cell tumors. J Natl Cancer Inst 81:1874–1878
Oosterhuis JW, Castedo SM, de Jong B, Conrelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H (1989) Ploidy of primary germ cell tumors of the testis Pathologenetic and clinical relevance. Lab Invest 60:14–21
Guerin S, Hawkins M, Shamsaldin A, Guibout C, Diallo I, Oberlin O, Brugieres L, de Vathaire F (2007) Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study. J Clin Oncol 25:2833–2839
Maity A, Shu H-KG, Judkins AR, Fisher MJ, Dwyer-Joyce LEA, Vaughn DJ (2004) Testicular seminoma 16 years after treatment for CNS germinoma. J Neurooncol 70:83–85
Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT (2003) Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys 56:511–518 [erratum appears in Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):306]
Shikama N, Ogawa K, Tanaka S, Toita T, Nakamura K, Uno T, Ohnishi H, Itami J, Tada T, Saeki N (2005) Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients. Cancer 104:126–134
Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U (2005) AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection Results of the cooperative trial MAKEI 89. Neuropediatrics 36:71–77
Strojan P, Zadravec LZ, Anzic J, Korenjak R, Jereb B (2006) The role of radiotherapy in the treatment of childhood intracranial germinoma: long-term survival and late effects [see comment]. Pediatr Blood Cancer 47:77–82
Hupperets PS, Defesche HF, de Bruijckere LM, Twijnstra A (1999) The role of chemotherapy in intracranial germinoma: a case report. Ann Oncol 10:723–726
Peat DS, Trowell JE (1994) Testicular seminoma in a patient with pineal germinoma. J Clin Pathol 47:771–772
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jabbour, S.K., Zhang, Z., Arnold, D. et al. Risk of second tumor in intracranial germinoma patients treated with radiation therapy: the Johns Hopkins experience. J Neurooncol 91, 227–232 (2009). https://doi.org/10.1007/s11060-008-9703-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-008-9703-5